Since we last walked... Advanced Sensor Development Accelerated – Artificial Pancreas Research JDRF in collaboration with the Helmsley Charitable Trust (HCT) formed partnerships with Medtronic and BD to advance continuous glucose monitoring (CGM) accuracy and reliability towards the next generation artificial pancreas systems. The goal of the partnerships is to accelerate the development and delivery of next generation sensor systems that are more accurate and reliable and easier to use. Improved CGMs will also be a key aspect of developing advanced generation artificial pancreas systems. Today’s CGM devices have significantly helped improve glucose control in people with T1D; next generation sensors will allow for more optimized insulin management with automated artificial pancreas systems. Both Medtronic and BD have reported successful animal study results with their new devices and are rapidly moving these into the clinical testing phase.
Posted on: Fri, 19 Jul 2013 17:52:46 +0000
Trending Topics
Recently Viewed Topics
© 2015